Effect of Weight Loss Amplitude Combined with Antiarrhythmic Drugs on Atrial Fibrillation Freedom, as compared to Catheter Ablation: A Sub-Analysis of the PRAGUE-25 Trial
In obese patients, the maintenance of SR on AADs is related to the level of weight reduction. The efficacy of AADs in obese patients with a significant weight loss at 12-months follow-up is close to catheter ablation, although the overall AF burden is still non-significantly higher.
Authors
- J Jarkovsky
- Milan Dusík (ORCID: https://orcid.org/0000-0003-0867-3077)
- Štěpán Havránek (ORCID: https://orcid.org/0000-0001-9694-0344)
- Adam Latiňák
- Dalibor Heřman (ORCID: https://orcid.org/0000-0002-7436-1154)
- Marek Hozman (ORCID: https://orcid.org/0000-0003-4111-4218)
- Ivan Ranič (ORCID: https://orcid.org/0009-0009-5489-7865)
- Otakar Jiravský (ORCID: https://orcid.org/0000-0001-9334-5734)
- Tomáš Roubíček (ORCID: https://orcid.org/0000-0001-8480-5110)
- Veronika Bulková (ORCID: https://orcid.org/0000-0003-0384-1895)
- František Lehár
- J SIMEK
- Jan Pidhorodecky
- Klára Benešová (ORCID: https://orcid.org/0000-0002-5603-9305)
- Hana Zelinková
- Jana Hozmanová
- Jana Veselá (ORCID: https://orcid.org/0000-0002-1048-2598)
- Zuzana Hejdukova
- P Osmancik
- Jan Chovancik
- Martin Matoulek
- Vladimir Tuka
- Bogna Jiravska–Godula
Institutions
- Charles University (CZ)
- Masaryk University (CZ)
- University Hospital Brno (CZ)
- Krajská Nemocnice Liberec (CZ)
- Nemocnice Podlesí (CZ)
- University Hospital Kralovske Vinohrady (CZ)
- General University Hospital in Prague (CZ)
Publication Details
- Journal
- EP Europace
- Published
- 2026-01-15
- DOI
- https://doi.org/10.1093/europace/euag013
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00